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AN INTERPRETIVE APPROACH:  
A CALL FOR STATE STATUTORY REFORM GOVERNING 
FETAL TISSUE DONATION 
 
Kirsten Eckroad* 
The controversy involving a sting of “leaked videos” of 
Planned Parenthood representatives discussing fetal tissue research 
starting July 2015 sparked public debate, threats of a federal 
government shutdown, and state legislative action across the United 
States. 1   Although the federal government narrowly avoided a 
shutdown over federal funding for Planned Parenthood, 2  pro-life 
advocates are still pushing for action to defund Planed Parenthood 
nationwide at the state level.  Four states, Arkansas, New Hampshire, 
Texas, and Utah defunded the organization, while other states have 
introduced legislation with intentions to defund Planned Parenthood.3  
 
The controversy started in mid-July 2015, when an anti-
abortion group, Center for Medical Progress (“CMP”), released 
footage of Planned Parenthood’s senior director, Dr. Deborah 
Nucatola, discussing the organization’s fetal tissue donation program.4  
In the video, Dr. Nucatola responds to fetal tissue procurement and 	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1 Jennifer Gerson Uffalussy, Catching Up on the Planned Parenthood Controversy: 
Everything You Need to Know, YAHOO! NEWS (Oct. 9, 2015), 
http://news.yahoo.com/catching-up-on-the-planned-parenthood-controversy-
184348775.html. 
2 Ted Barrett & Dierdre Walsh, Congress Avoids Government Shutdown, CNN 
POLITICS (Sept. 30, 2015, 5:49 PM), 
http://www.cnn.com/2015/09/30/politics/government-shutdown-2015-funding-vote-
senate-continuing-resolution/ (“Just seven hours before federal agencies ran out of 
money, the House of Representatives on Wednesday passed a bill funding the federal 
government through Dec. 11.”). 
3 Deborah Netburn, After Texas Stopped Funding Planned Parenthood, Low-Income 
Women Had More Babies, LA TIMES (Feb. 3, 2016), 
http://www.latimes.com/science/sciencenow/la-sci-sn-planned-parenthood-texas-
births-20160203-story.html. 
4 Steve Almasy & Eliott C. McLaughlin, Planned Parenthood Exec, Fetal Body 
Parts Subject of Controversial Video, CNN (July 15, 2015, 7:34 PM), 
http://www.cnn.com/2015/07/15/health/planned-parenthood-undercover-video/. 
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donation inquiries with undercover CMP members, posing as 
representatives of a human biologics company.5  That video was only 
the first of at least ten videos released by CMP6 accusing Planned 
Parenthood of profiting off of aborted fetuses.7  These videos not only 
channeled a long-standing disconnect between pro-life and pro-
choicers involving the debate surrounding abortions, but it seriously 
called into question the legitimacy of donating fetal tissue for research 
for the first time in over 25 years.8   
 
Independent forensic analysis of the tapes revealed heavily 
edited footage; large portions of the videos were cut out and separate 
footage was paired together, transcripts were typed incorrectly,9 and a 
stolen stillborn photograph was taken off the web, portrayed to be a 
19-week aborted fetus. 10   Moreover, experts say that the 
reimbursement estimate per specimen11 given by Dr. Nucatola in the 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
5 Id.   
6 Rachana Pradhan, Anti-Abortion Group Releases 10th Video, POLITICO (Sept. 15, 
2015, 10:14 AM), http://www.politico.com/story/2015/09/planned-parenthood-
undercover-video-10th-213633. 
7 David Daleidan, Planned Parenthood’s Top Doctor, Praised by CEO, Uses 
Partial-Birth Abortions to Sell Baby Parts, THE CENTER FOR MEDICAL PROGRESS 
(July 14, 2015, 8:00 AM), 
hyyp://www.centerformedicalprogress.org/2015/07/planned-parenthoods-top-doctor-
praised-by-ceo-uses-partial-birth-abortions-to-sell-baby-parts/.  
8 In 1988, a temporary moratorium was placed on federal funds for fetal tissue 
research while researchers studied the likelihood that research with fetal tissue would 
increase the frequency of induced abortions. Although that panel of researchers 
reported that the use of fetal tissue for research was acceptable public policy, the 
moratorium wasn’t lifted until President Bill Clinton took office in 1993. See James 
E. Goddard, The NIH Revitalization Act of 1993 Washed Away Many Legal 
Problems with Fetal Tissue Transplantation Research but a Strain Still Remains, 49 
SMU L. REV. 375, 383–384 (1996). 
9 Laura Bassett, “Sting” Videos of Planned Parenthood Are Totally Manipulated, 
Forensic Analysis Finds, HUFFPOST POLITICS (Aug. 28, 2015, 11:09 AM), 
http://www.huffingtonpost.com/entry/planned-parenthood-sting-videos-
forensic_55df2334e4b029b3f1b1be9f. 
10 Drew Griffin and David Fitzpatrick, The Real Story Behind Those Planned 
Parenthood Videos, CNN POLITICS (Oct. 20, 2015, 8:46 AM), 
http://www.cnn.com/2015/10/19/politics/planned-parenthood-videos/. 
11 When asked, Dr. Nucatola quoted a $30 to $100 price range per patient for fetal 
tissue procurement. This price range was later portrayed by CMP as an attempted 
price quote to conduct a sale of fetal tissue parts. See Dave Levitan, Unspinning the 
Planned Parenthood Video, FACTCHECK.ORG 
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footage, later attacked by opponents, is actually a “reasonable charge 
for clinical operations to recover costs”—an act that is not against 
federal law.12  
 
This Comment argues that states should legalize fetal tissue 
donation.  By taking an interpretative approach, this Comment will 
demonstrate that state statutory language governing fetal tissue 
donation introduces unnecessary ambiguity.  Section I will analyze the 
legal status of fetal tissue donation at the federal and state levels.13  
After sorting through the ambiguity of state statutes governing fetal 
tissue, this Comment will then analyze the legality of Planned 
Parenthood’s actions.  Section II will address the multitude of 
arguments comprising the fetal tissue donation debate to highlight the 
importance of fetal tissue donation.14  Section III will propose a two-
part revision for state legislators in order to resolve ambiguity and 
effectively enable fetal tissue donations.15  
 
I. LEGAL STATUS: FETAL TISSUE DONATION 
A. Federal Law  
Federal law is an important starting point in understanding 
fetal tissue donation rights in the United States.  Federal law provides 
a minimum level of rights that states may not fall below, commonly 
referred to as the “federal floor” of rights.16  However beyond this 
floor, states are free to enact additional statutory and court-made state 
rights.17  Although state law provides an additional source of rights to 
state citizens, this section will first address federal standards 
concerning fetal tissue donation.  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(July 21, 2015), http://www.factcheck.org/2015/07/unspinning-the-planned-
parenthood-video/. 
12 Id. Dr. Sherilyn J. Sawyer, director of Harvard University and Brigham and 
Women’s Biorespository, added that given all of the costs associated with storage 
and collection, “In reality, $30 [to] $100 probably constitutes as loss” for Planned 
Parenthood. Id.  
13 See infra, Section I.  
14 See infra, Section II.  
15 See infra, Section III.  
16 Michael E. Solimine & James L. Walker, State Court Protection of Federal 
Constitutional Rights, 12 HARV. J.L. & PUB. POL'Y 127, 151 (1989).  
17 Id. 
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Tissue donation policy begins with the understanding that 
abortion is legal.18  In 1973, the United States Supreme Court held that 
women have a constitutionally protected right to abortion in the 
landmark decision, Roe v. Wade.19  Despite ongoing challenge, a 
woman’s right to choose was reaffirmed in 1992 Supreme Court 
decision Planned Parenthood v. Casey,20 which also confirmed state 
regulations on abortion, as long as the regulations do not impose an 
“undue burden” on women seeking an abortion.21  Thus, with the 
understanding that abortion is legal in the United States—in fact 1.2 
million legal abortions occur every year—the question of what to do 
with aborted material emerges.22  
 
Federal law allows and funds fetal tissue donation, subject to 
certain restrictions.  Section 42 U.S.C. §289g-1 was enacted to allow 
research involving fetal tissue donation, “regardless of whether the 
tissue is obtained pursuant to a spontaneous or induced abortion or 
pursuant to a stillbirth.”23  The statute provides federal funding for 
donation of fetal tissue after an induced abortion under three 
conditions: (1) The abortion was performed in accordance with any 
state law, (2) the aborting woman’s consent for the abortion “was 
obtained prior to requesting . . . consent for a donation of the tissue,” 
and 3) there was “no alteration of the timing, method, or procedures 
used to terminate the pregnancy.”24  
 
Individuals involved in fetal tissue donation are prohibited 
from certain actions in 42 U.S.C. §289g-2. First, purchase of fetal 
tissue for “valuable consideration” is prohibited in section 42 U.S.C. 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
18 Roe v. Wade, 410 U.S. 113 (1973) (holding in part that under the Due Process 
Clause of the Fourteenth Amendment that there is a constitutional right to abortion 
within the first trimester of pregnancy).  
19 Id.  
20 505 U.S. 833 (1992)	  
21 Id. at 874 (citing Justices O’Connor, Kennedy, and Souter). 
22 Rachel K. Jones & Kathryn Kooistra, Abortion Incidence and Access to Services 
in the United States, 2008, 43 PERSPECTIVES ON SEXUAL AND REPRODUCTIVE 
HEALTH 41, 41 (2011), http://www.guttmacher.org/pubs/psrh/full/4304111.pdf.  
23 42 U.S.C. § 289g-1(a) (2012). 
24 42 U.S.C. § 289g-1(b)(2)(A) (2012). Section (a)(1) of 42 U.S.C. §289g-1 provides 
the general establishment of the program, stating, “The Secretary may conduct or 
support research on the transplantation of human fetal tissue for therapeutic 
purposes.” 42 U.S.C. § 289g-1(a)(1) (2012). 
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§289g-2(a), 25  although the term valuable consideration does not 
include “reasonable payments associated with the transportation, 
implantation, processing, preserving, quality control, or storage of 
human fetal tissue.”26  This section also prohibits the acceptance of 
donated tissue from an induced abortion where the donation is either 
“made pursuant to a promise” that it will be used in a specific way, or 
if the abortion was deliberately induced to provide fetal tissue.27  
Section 42 U.S.C. §289g-2(d) sets out criminal penalties to any person 
who violates these prohibitions.28  
 
 The Code of Federal Regulations restricts federal funding for 
certain actions by researchers.29  45 C.F.R. §46.204 states that “no 
inducements, monetary or otherwise, will be offered to terminate a 
pregnancy.”30  This provision also restricts researchers’ involvement 
with women considering abortions, or in determining the viability of a 
fetus that is aborted alive. 31   Specifically, 45 C.F.R. §46.204(i) 
provides that “individuals engaged in research will have no part in any 
decisions as to the timing, method, or procedures used to terminate a 
pregnancy,” nor in “determining the viability of the neonate.”32 
 
Thus under federal law, fetal tissue donation is legal and 
federally funded so long as researchers comply with the restrictions 
discussed above.  Individuals violating prohibitions associated with 
fetal tissue donation risk criminal penalties.  However, beyond this 
federal floor of rights many states have enacted their own legislation 
concerning fetal tissue donation. 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
25 42 U.S.C. § 289g-2(a) (2012). 
26 42 U.S.C. § 289g-2(e)(3) (2012). 
27 42 U.S.C. §§ 289g-2(b), 289g-2(c) (2012). 
28 Individuals who violate this section may be subject to fines and/or prison 
sentences of up to ten years. 42 U.S.C. § 289g-2(d) (2012). 
29 The authority for 45 C.F.R. § 46.204 is set out in 42 U.S.C. § 289(a). See 42 
U.S.C. § 289(a) (2015) (“The Secretary, acting through the Director of NIH, shall by 
regulation require appropriate technical and scientific peer review of . . . applications 
made for grants and cooperative agreements under this chapter for biomedical and 
behavioral research”).  
30 45 C.F.R. § 46.204(h) (2015). 
31 45 C.F.R. § 46.204(i) (2015). 
32 Id. 
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B. State Law  
While federal law sets the floor of rights that states may not 
reduce, state law is often the source of most individual rights.33  State 
law governing fetal tissue donation varies considerably and is often 
vague and confusing.  The Uniform Anatomical Gift Act (UAGA), 
first promulgated in 1968, was a remedial attempt by the National 
Conference of Commissioners on Uniform State Laws (NCCUSL) to 
create uniform laws for organs transplant provision across the states.34   
The 2006 version of the UAGA has been enacted in forty-seven states 
plus the District of Columbia.35 
 
Despite nearly uniform enactment of the latest UAGA, 
considerable variability still exists in regards to the legality of fetal 
tissue donation in the states.  Although the 2006 UAGA unanimously 
restricts the sale of donated materials, such clarity does not exist 
across the states for the general legal status of donating fetal tissue.  
This is due to the fact that the 2006 UAGA left open the option for 
states to include additional restrictions governing fetal tissue 
donation.36  Thus, even jurisdictions that enacted the 2006 UAGA vary 
considerably when it comes to fetal tissue donation.37  Language of 
state statutes governing fetal tissue donation fall into three different 
categories: language that allows fetal tissue donation, language that 
does not prohibit fetal tissue donation, and language that prohibits 




 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
33 Solimine & Walker, supra note 16, at 151. 
34 UNIFORM LAW COMMISSION, Anatomical Gift Act (2006) Summary, 
http://www.uniformlaws.org/ActSummary.aspx?title=Anatomical%20Gift%20Act%
20(2006) (last visited Mar. 5, 2016) [hereinafter Anatomical Gift Act (2006)] 
35 UNIFORM LAW COMMISSION, Legislative Fact Sheet – Anatomical Gift Act (2006), 
http://www.uniformlaws.org/LegislativeFactSheet.aspx?title=Anatomical%20Gift%
20Act%20(2006) (last visited Mar. 5, 2016). 
36 Id.  
37 See 755 ILL. COMP. STAT. 50/1-10 (2014) (defining “decedent” which may be 
donated as an anatomical gift broadly to include “stillborn infant or fetus”); but see 
KY. REV. STAT. ANN. § 311.1911 (West 2016) (defining “decedent” to include fetus, 
but not a “fetus that was the subject of an induced abortion”). 
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1. State Statutory Language that Allows Fetal Tissue Donation 
 
 The first category is of states that allow fetal tissue donation.  
Typically, these state UAGA’s include “fetus” in the definition of a 
“decedent” that may be donated as an anatomical gift.38  The definition 
of decedent suggested by the NCCUSL in the 2006 UAGA is “a 
deceased individual whose body or part is or may be the source of an 
anatomical gift.39  The 2006 UAGA includes language stating that 
decedent “includes a stillborn infant and, subject to restrictions 
imposed by law other than this [act], a fetus” [emphasis added].40  
However, the states in this category do not include the phrase “subject 
to restrictions imposed by law other than this [act]” in their state 
UAGA definition of decedent, unambiguously allowing the donation 
of fetal tissue.41  Nine states currently fall into this category.42  States 
falling into the remaining two categories are much less clear on the 
question of whether or the manner in which fetal tissue may be 
donated.   
 
2. State Statutory Language that Does Not Prohibit Fetal 
Tissue Donation 
 
The majority of state statutory language is much less explicit 
regarding the legality of fetal tissue donation.  Most states do not 
explicitly allow fetal tissue donation—they merely do not restrict it.  
These states fall into one of two subcategories.  The first, which 
twenty-six states fall into, includes states that define “decedent” to 
include fetal tissue donation subject to “other restrictions imposed by 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
38 Id. 
39 UNIFORM LAW COMMISSION, Revised Uniform Anatomical Gift Act (2006) (Last 
Revised or Amended in 2009), 
http://www.uniformlaws.org/shared/docs/anatomical_gift/uaga_final_aug09.pdf. 
40 Id.  
41 An example of such language defining decedent is as follows: “‘Decedent’ means 
a deceased individual and includes a stillborn infant or fetus.” DEL. CODE ANN. tit. 
16, § 2710 (West 2016). 
42 See DEL. CODE ANN. tit. 16, § 2710 (West 2016); GA. CODE ANN. § 44-5-141 
(West 2016); 755 ILL. COMP. STAT. 50/1-10 (2014); MASS. GEN. LAWS ANN. ch. 
113A, § 2 (West 2016); MONT. CODE ANN. § 72-17-102 (West 2016); N.J. STAT. § 
26:6-78 (2015); N.Y. PUB. HEALTH LAW § 4300 (2016); OR. REV. STAT. § 97.953 
(2013); 20 PA. STAT. AND CONS. STAT. § 8601 (2000). 
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law,” yet no other restrictions exist.43  An illustration of this category 
of state statutes is as follows: “‘Decedent’ means a deceased 
individual whose body or part is or may be the source of an anatomical 
gift.  The term includes a stillborn infant and, subject to restrictions 
imposed by law other than this article, a fetus.”44  
 
The second category includes four states that are silent as to 
fetal tissue donation.45  These states do not specifically enumerate fetal 
tissue in their UAGA definition, and have no other legislation 
governing fetal tissue donation.  The following is an example of the 
definition of “decedent” that these states have adopted: “‘Decedent’ 
means a deceased individual whose body or body parts may be, or are, 
the source of an anatomical gift.”46  Since these states are silent on the 
subject of fetal tissue donation, they do not restrict fetal tissue 
donation. 
 
3. State statutory language that prohibits fetal tissue donation 
after an induced abortion  
 
 The remaining twelve states expressly prohibit fetal tissue 
donation from induced abortions.47  These states define decedent in 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
43 See ALA. CODE § 22-19-161 (2015); ALASKA STAT. ANN. § 13.52.173 (West 
2015); ARIZ. REV. STAT. ANN. § 36-841 (2016); ARK. CODE ANN. § 20-17-1202 
(West 2015); CAL. HEALTH & SAFETY CODE ANN. § 7150.10 (West 2016); COLO. 
REV. STAT. ANN. § 12-34-102 (West 2015); CONN. GEN. STAT. ANN. § 19a-289a 
(West 2015); D.C. CODE § 7-1531.01 (2015); HAW. REV. STAT. § 327-2 (LexisNexis 
2015); IDAHO CODE ANN. § 39-3402 (West 2015); IND. CODE ANN. § 29-2-16.1-1 
(West 2015); KAN. STAT. ANN. § 65-3221 (West 2015); ME. REV. STAT. tit. 22, § 
2942 (2015); MISS. CODE. ANN. § 41-39-103 (West 2015); NEV. REV. STAT. ANN. § 
451.520 (West 2015); N.H. REV. STAT. ANN. § 291-A:2 (2015); OHIO REV. CODE 
ANN. § 2108.01 (West 2015); OKLA. STAT. ANN. tit. 63, § 2200.2A (West 2015) R.I. 
GEN. LAWS ANN. § 23-18.6.1-2 (West 2015); TENN. CODE ANN. § 68-30-102 (West 
2015); TEX. HEALTH & SAFETY CODE ANN. § 692A.002 (Vernon 2015); UTAH CODE 
ANN. § 26-28-102 (West 2015); VT. STAT. ANN. tit. 18, § 5250b (West 2015); VA. 
CODE ANN. § 32.1-291.2 (West 2015); W. VA. CODE ANN. § 16-19-3 (West 2015); 
WYO. STAT. ANN. § 35-5-202 (West 2015). 
44 ALA. CODE § 22-19-161 (West 2015). 
45 See FLA. STAT. ANN. § 765.511 (West 2015); S.C. CODE ANN. § 44-43-305 (West 
2015); WASH. REV. CODE ANN. § 68.64.010 (West 2015); WIS. STAT. ANN. § 157.06 
(West 2015).  
46 FLA. STAT. ANN. § 765.511 (West 2015). 
47 See IOWA CODE ANN. § 142C.2 (West 2015); KY. REV. STAT. ANN. § 311.1911 
(West 2015); LA. STAT. ANN. 17:2351 (West 2015); MD. EST. & TRUSTS CODE ANN. 
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their relevant UAGA either to restrict donations to stillborn fetuses, to 
prohibit donation of a fetus from an induced abortion, or to prohibit 
donation of any fetus.48  A clear restriction of fetal tissue donation 
from an induced abortion is as follows: 
 
(4) “Decedent” means a deceased individual whose 
body or part is or may be the source of an anatomical 
gift. The term includes a stillborn infant and, subject to 
restrictions imposed by law other than [this act], a 
fetus; however, the term “fetus” does not include a 
blastocyst, embryo, or fetus that was the subject of an 
induced abortion.49  
 
 Slightly differently worded statutory language defines decedent 
as “a deceased individual whose body or part is or may be the source 
of an anatomical gift.  The term includes a stillborn infant or an 
embryo or fetus that has died of natural causes in utero.”50  Both sets 
of language have the same result: prohibiting fetal tissue donated from 
an induced abortion.   
 
Other state UAGA provisions in this category are more 
ambiguous.  For example, Iowa’s UAGA expresses that decedent is a 
“deceased individual whose body or part is or may be the source of an 
anatomical gift and includes a stillborn infant.” 51  By only mentioning 
a stillborn infant, the statute can be interpreted to somewhat unclearly 
prohibit fetal tissue from other sources.  Similarly, Missouri’s 
legislature obscurely prohibits donation of fetal tissue from induced 
abortions, but allows research with such fetal tissue.  For example, 
Missouri’s UAGA defines decedent as “not includ[ing] an unborn 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
§ 4-501; MICH. COMP. LAWS ANN. § 333.10102 (West 2015); MINN. STAT. ANN. § 
525A.02 (West 2015); MO. REV. STAT. ANN. § 194.210 (West 2015); NEB. REV. 
STAT. § 71-4825 (West 2015); N.M. STAT. ANN. § 24-6B-2 (West 2015; N.C. GEN. 
STAT. ANN. § 130A-412.4 (West 2015); N.D. CENT. CODE ANN. § 23-06.6-01 (West 
2015); S.D. CODIFIED LAWS § 34-26-49 (West 2015).  
48 The only state that prohibits donation of any fetus is Louisiana. (“(4) ‘Decedent’ 
means a deceased person whose body or part is or may be the source of an 
anatomical gift. The term does not include a stillborn infant and, subject to 
restrictions imposed by law, a fetus . . . .”) LA. STAT. ANN. §17:2351 (West 2015).  
49 KY. REV. STAT. ANN. § 311.1911 (West 2015) (emphasis added). 
50 MINN. STAT. ANN. § 525A.02 (West 2015) (emphasis added). 
51 IOWA CODE ANN. § 142C.2 (West 2015). 
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child . . . if the child has not died of natural causes,”52 while separately 
prohibiting use of fetal tissue only if the researcher “knows that the 
abortion was procured for the purpose of utilizing those organs or 
tissue for such use.”53  Case law on these state UAGA provisions 
provide little clarity; of the rare questions courts have considered 
involving anatomical gifts, the facts are limited to cases involving 
mature donors after death, not tissue from aborted fetuses.54  
 
C. Federal and State Laws As Applied to Planned 
Parenthood’s Actions  
 
 By accepting reasonable reimbursements and procuring fetal 
tissue donations in Washington, Oregon, and California, Planned 
Parenthood did not violate federal or state laws.  In a letter written to 
the National Institutes of Health (NIH) on October 13, 2015, the 
president of Planned Parenthood, Cecile Richards, made two 
admissions that this section’s analysis will be based on.  She first 
admitted that three states or one percent of their health centers —
Washington, Oregon, and California—participate in donation of fetal 
tissue.55  Ms. Richards also admitted that up until the date of her letter, 
Planned Parenthood had been accepting reasonable reimbursements 
under 42 U.S.C. §289g-2.  However, Ms. Richards announced on 
October 13, 2015, that Planned Parenthood would no longer accept 
reasonable reimbursements.56  Stating that although the organization 
never received payments beyond those legal reimbursements, as an 
attempt to debunk the arguments supplied by opponents, Planned 
Parenthood would no longer accept such legal payments.57   
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
52 MO. REV. STAT. ANN. § 194.210 (West 2015). 
53 Id. at § 188.036 (West 2015). 
54 See Mansaw v. Midwest Oregon Bank, 1998 WL 386327, 1 (W.D. Miss. July 8, 
1998) (discussing donation of organs after the death of the parties 15-year-old son); 
See also Alchor Life Extension Foundation v. Richardson, 785 N.W.2d 717, 719 
(concerning 82-year-old decedent’s remains which decedent intended to donate to 
cryonics).  
55 Id.  
56 Brakkton Booker, Planned Parenthood Will No Longer Accept Reimbursement 
For Fetal Tissue, NPR (Oct. 13, 2015), http://www.npr.org/sections/thetwo-
way/2015/10/13/448288996/planned-parenthood-will-no-longer-accept-
reimbursement-for-fetal-tissue.  
57 Id.  
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Planned Parenthood’s actions are not in violation of federal 
law.  Despite accusations that Planned Parenthood illegally profited 
off of “selling aborted baby parts,” Planned Parenthood only received 
reasonable reimbursements for costs associated with procurement, as 
permitted under federal law.58  Although Planned Parenthood has 
decided to no longer receive such reimbursements, human tissue 
procurement experts agree that the amount previously reimbursed was 
“reasonable” for clinical reimbursement costs. 59   In fact, experts 
estimate that the $30 to $100 clinical reimbursement figure Planned 
Parenthood once agreed to receive likely constituted a “loss” for the 
organization, not a profit.60  
 
Nor are Planned Parenthood’s actions are in violation of state 
law.  None of the three states where Planned Parenthood facilitates 
fetal tissue procurement prohibit fetal tissue donation.  Oregon falls 
into the first category of states identified above that explicitly allow 
fetal tissue donation under their state-enacted UAGA.61  California and 
Washington are among the second category of states discussed above 
that do not prohibit fetal tissue donation. 62   Thus, contrary to 
allegations set forth by CMP, the actions taken by Planned Parenthood 
in facilitation of fetal tissue donation are not in violation of federal or 
state law.   
 
II. THE FETAL TISSUE DONATION DEBATE 
Although at the center of the current controversy involving 
Planned Parenthood, the debate over fetal tissue donation is not a new 
one.63  While researchers have been experimenting with fetal tissue 
since the 1930s, opposition to fetal tissue research began when 
abortion was legalized in the 1970s.64  This section will demonstrate 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
58 Reasonable reimbursements under the statute include payments for 
“transportation, implantation, processing, preservation, quality control, or storage of 
human fetal tissue.” 42 U.S.C. §289g-2 (2012). 
59 See Levitan, supra note 11. 
60 Id. 
61 OR. REV. STAT. ANN. § 97.953 (West 2015).  
62 CAL. HEALTH & SAFETY CODE § 7150.10 (West 2015); WASH. REV. CODE ANN. § 
68.64.010 (West 2015).  
63 Angela M. Skerrett, Fetal Tissue Research and Abortion: Do They Have a Future 
Together? 13 CAMPBELL L. REV. 81, 82 (1990).  
64 Id. at 82–83.  
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that despite ongoing efforts to restrict the use of fetal cells for 
research, fetal tissue research continues to be imperative.  This section 
will first discuss the importance of fetal tissue donation and then 
address concerns expressed by opponents.   
 
A. The Importance of Fetal Tissue Donation  
Due to the unique characteristics of fetal tissue cells, research 
with donated fetal tissue has proved particularly promising in 
extensive areas of health and science.  While the search for 
alternatives to fetal cells continues, the use of fetal tissue cells for 
research remains imperative to advances in modern medicine.  
 
1. Uniqueness of Fetal Tissue Cells  
 Fetal tissue has unique characteristics, which make it ideal for 
successful transplantation and research.65  Fetal cells have the ability 
to grow and reproduce rapidly.66  These properties of fetal tissue, 
when transplanted, can lead to quick reversal in the donee’s area of 
impairment.67  Since fetal cells are also extremely adaptable, they can 
easily survive excision, dissection, and low-oxygen conditions, all 
which take place either before or during transplantation.68  
 
 Once transplanted, fetal cells also interact particularly well 
within the environment of the receiving host. 69   These cells are 
proficient at responding to environmental cues around them, enabling 
them to make connections with others cells in the host.70  Additionally, 
because fetal cells usually lack lymphocytes and have less 
histocompatibility antigens present in adult cells, they are less likely to 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
65 Valerie J. Janosky, Stem Cells: Potential Cures or Abortion Lures?, 6 DEPAUL J. 
HEALTH CARE L. 111, 116 (2002).  
66 Jose L. Gonzalez, The Legitimization of Fetal Tissue Transplantation Research 
Under Roe v. Wade, 34 CREIGHTON L. REV. 895, 909 (2001).  
67 For example, patients suffering from Parkinson’s Disease can replace dead 
neurons with fetal brain cell transplantation to “produce necessary 
neurotransmitters.” See Janosky, supra note 65, at 118–19.  
68 For example, the affected area of the brain for patients with Parkinson’s. Id. at 
116–17.  
69 Id. at 116.   
70 Id.  
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produce “graft vs. host” reactions. These characteristics in fetal cells 
make them much less likely to be rejected in the host than adult cells.71  
 
2. Success of Fetal Tissue Research  
 
 Due to fetal cells’ unique properties, fetal tissue research has 
been incredibly successful.  Commentators have gone as far as saying 
that “virtually every person in this country has benefited from research 
using fetal tissue.”72  Research with fetal tissue is estimated to have 
saved millions of lives, including, ironically, the lives of unborn 
children in the womb, by preventing thousands of miscarriages each 
year due to creation of the rubella vaccine. 73   Other successful 
vaccines generated from fetal tissue research include hepatitis A, 
chickenpox, measles, and rabies.74  
 
 Perhaps most notably, fetal tissue experimentation has lead to 
treatments for many diseases that were once believed to have no 
cure. 75   Most recently, research with fetal tissue has produced 
promising results for Parkinson’s disease.  Studies of the over 100 
Parkinson’s patients who have received fetal tissue transplantation 
surgeries have been particularly beneficial, especially for young 
patients in the early stages of the disease.76  In addition, scientists 
estimate that fetal tissue research has the potential to advance other 
areas of medicine, including a variety of blood disorders and age-
related blindness.77  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
71 Id. 
72 R. Alta Charo, Fetal Tissue Fallout, N. ENG. J. MED. 890, 890 (2015), 
http://www.nejm.org/doi/full/10.1056/NEJMp1510279#.VcvA8l6Hh3c.twitter.  
73 Tara Culp-Ressler, The Use of Aborted Fetuses in Medical Research has ‘Saved 
the Lives and Health of Millions,’ THINKPROGRESS.ORG (Aug. 13, 2015, 10:16am), 
http://thinkprogress.org/health/2015/08/13/3691269/fetal-tissue-moral-case/ (quoting 
Charo, supra note 72).  
74 Collin Binkley & Carla K. Johnson, Scientists Say Fetal Tissue Remains Essential 
for Vaccines and Developing Treatments, PBS, Aug. 11, 2015, 
http://www.pbs.org/newshour/rundown/medical-researchers-say-fetal-tissue-
remains-essential/. 
75 See Janosky, supra note 65, at 117.  
76 Shari E. Gelber et. al., Fetal Tissue Research: An Ongoing Story of Professionally 
Responsible Success, AM. J. OBSTETRICS & GYNECOLOGY (2015), 
http://dx.doi.org/10.1016/j.ajog.2015.09.079.   
77 See Janosky, supra note 65, at 117 (“Fetal tissue transplants have been promising 
for patients suffering from Alzheimer's disease, spinal cord and other neural tissue 
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3. Alternatives Insufficient  
 
 Opponents of fetal tissue research argue that there are 
sufficient alternatives to replace aborted fetal tissue cells, such as 
tissue from cadavers and living donors, fetal tissue from non-induced 
abortions, or 3D bioprints.78   This Section will demonstrate that 
contrary to such arguments, each of these proposed alternatives remain 
insufficient to replace fetal tissue research. 
 
a. Living Donors  
 The prevailing shortage of donations from living donors 
prohibits donations from living donors being a sufficient alternative.  
The Uniform Anatomical Gift Act was enacted, in large part in 
response to the longstanding shortage of organ transplants.79  Despite 
recent campaigns, technological advances, and federal and state 
efforts, insufficiency of organs and tissue donations linger.80  It is 
estimated that less than 20 percent of accident victims donate their 
organs,81 and that one person per hour dies waiting for an organ 
transplant.82  Thus, adding fetal tissue research to a waitlist already in 
a shortage cannot possibly be considered a sufficient alternative to the 
use of donated fetal tissue cells.  
 
 In the ideal world, where there is no shortage of donations 
from living donors, such donation from organ donors would still not 
suffice to replace fetal tissue cells.  As discussed earlier, fetal tissue 
cells have unique characteristics that allow them to easily survive 
research conditions and to react well with receiving host.  While fetal 
cells are able to rapidly grow and reproduce, cells from mature living 
donors are typically unable to reproduce, limiting the use and number 
of recipients that can benefit from such cells.83  Additionally, when 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
injuries, diabetes, some forms of blindness, and are used to treat blood-clotting 
disorders, such as sickle cell anemia, thalassemia, and hemophilia . . .”).  
78 Id. at 152. 
79 See generally Anatomical Gift Act (2006), supra note 34.  
80 Kimberly Fox Duguay, Academic Article: Fetal Tissue Transplantation: Ethical 
and Legal Considerations, 1 CIRCLES BU. W. J. L. & SOC. POL. 33, 34 (1992). 
81 Id.  
82 See Anatomical Gift Act (2006), supra note 33. 
83 See Duguay, supra note 80, at 34. 
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used for transplantation, adult cells are more likely to be identified as 
foreign in a recipient’s body due to antigens and other markers, 
making these (already limited) cells much more likely to be rejected.84  
 
b. Fetal Tissue from Non-Induced Abortions 
 
 Limiting fetal tissue donation to only sources other than 
induced abortions are insufficient. 85   Over 1.2 million elective 
abortions occur each year, making such elective, or induced, abortions 
the most common source of donated fetal tissue. 86   Opponents, 
presumably recognizing the importance of research involving fetal 
tissue, argue that fetal cells should be procured, but only from sources 
that do not include induced abortions, such as stillbirths, miscarriages, 
or ectopic pregnancies.87 
 
  Since stillbirths occur at a minimum of 20 weeks of gestation 
by definition, they are usually not suitable for certain fetal tissue 
research uses, such as transplantation.88  Additionally, by the time 
stillborn fetuses are expelled from the mother’s body, the fetal tissue is 
usually dead and thus unable to be cultured for research.89  The same 
is true for miscarriages.  While as many as 20 percent of pregnancies 
end in miscarriage within the first trimester, by the time fetal tissue is 
expelled, potentially full days after the fetal death, the fetal tissue is 
usually unsuitable for research.90  For both stillbirths and miscarriages, 
the reason for fetal death itself could stand in the way of suitability for 
fetal tissue research.91   
 
  Ectopic pregnancies, pregnancies implanted erroneously in 
areas other than the mother’s uterus, are estimated to occur in less than 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
84 Id.  
85 Keith J. Allred, Fetal Tissue Transplants: A Primer with a look Forward, 28 J. 
HEALTH & HOSP. L. 193, 195 (1995).  
86 See Jones & Kooistra, supra note 22, at 41.  
87 See Allred, supra note 85, at 195. 
88 For example, transplantation including neural tissue must be obtained from a fetus 
twelve weeks gestated or less. Id.	  
89 Id. 
90 Id.  
91 See Gregory Gelfand & Toby R. Levin, Fetal Tissue Research: Legal Regulation 
of Human Fetal Tissue Transplantation, 50 WASH. & LEE L. REV. 647, 652 (1993) 
(noting the possibility that a defective fetal pathology may have caused the fetal 
death, making it unsuitable for research). 	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17 of 1000 reported pregnancies.92  Since the pregnancy would result 
in the death of the mother if carried to term, there is less opposition to 
abortions in such cases.93  However, given common at-home therapies 
to terminate ectopic pregnancies, no reliable form of collection of such 
aborted materials exist.94  Even where less-common surgical removals 
of ectopic pregnancies take place, fetal materials are commonly 
“morphologically abnormal,” and unfit for research.95  
 
 c. 3D Bioprints  
 
 While other alternatives to fetal tissue, such as computer 
models, appear promising in their early stages, they are not yet 
sufficient alternatives to fetal tissue.96  By way of example, a recent 
proposed alternative to fetal tissue research is the use of three-
dimensional bioprints of human organs.  These computer-generated 
bioprints are formed through compositional analysis and a printed 
creation of a desired human tissue, produced in a multiple-layer 
format.97  These printed “tissues” are built up vertically, and created in 
a range of 3D formats.98  However, because biological processes are 
still not fully understood, these prints can be inaccurate.99  “If we want 
to study a process,” a Johns Hopkins professor explains, “it’s best to 
study the real thing.”100  Indeed, advances in medicine and technology 
have given hope of sources such as 3D bioprints, for the research 
conducted with fetal tissue. 101   Yet since no current sufficient 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
92 See Allred, supra note 85, at 195. 
93 Id.  
94 Id. 
95 Id.  
96 Andrea K. McDaniels & Meredith Cohn, Scientists Say Fetal Tissue Important in 
Research, BALT. SUN (Aug. 15, 2015), http://www.baltimoresun.com/health/bs-hs-
fetal-tissue-20150815-story.html. 	  
97 Organovo Holdings Inc., The Bioprinting Process, YOUTUBE (Apr. 16, 2013), 
https://www.youtube.com/watch?v=s3CiJ26YSU. 
98 Id.  
99 See McDaniels & Cohn, supra note 96 (“Models can be insufficient in mimicking 
what we want to study . . .We can make a little bit of skin in the lab or cartilage, but 
not organs. For that, there is more complicated interplay.”).  	  
100 Id.  
101 Id. 
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alternative to fetal tissue exists, it is imperative that its use and 
donation is not restricted.102 
 
B. Arguments Against Fetal Tissue Donation 
 
Arguments against fetal tissue donation commonly focus on 
the viewpoint that fetal tissue donation encourages abortion, causes 
undue influence on pregnant women, and is immoral.103  Critics argue 
that if fetal tissue research shows promise, pregnant women will be 
more likely to have abortions,104 and more likely to choose to have 
abortions so they can donate fetal tissue to a cherished cause or to a 
sick loved one.105  Essentially, the overall number of abortions will be 
higher because women are more likely to have an abortion if they 
know beneficial use can be made of the fetal tissue aborted.106   
  
If women are not more likely to choose abortions, opponents 
alternatively argue that researchers involved with fetal tissue donation 
will encourage pregnant women to have abortions.107  Physicians 
running low on fetal tissue materials will adopt not-so-neutral 
responses, opponents argue, when women request advice on their right 
to choose to abort.108  This idea is grounded in the concept that when 
fetal tissue donation is an available option, physicians who have 
personal interests for acquiring fetal tissue will directly, or even 
indirectly, unduly influence and convince a woman to decide in favor 
of an abortion.109   
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
102 See Alison Abbot, Fetal-Cell Revival for Parkinson’s, 510 NATURE 195, 196 
(2014), http://www.nature.com/news/fetal-cell-revival-for-parkinson-s-1.15387 
(“We don’t know yet which source of cell will turn out to be the best, but right now 
the fetal cell is the gold standard we need to match . . .”). 
103 Cory Zion, Comment, The Legal and Ethical Issues of Fetal Tissue Research and 
Transplantation, 75 OR. L. REV. 1281, 1285–87 (1996).  
104 Id. at 1285.  
105 Id. For example, a women choosing to abort in order to donate fetal tissue 
towards transplantation for her father suffering from Parkinson’s disease. Id.  
106 Beverly Ray Burlingame, Note, Commercialization in Fetal-Tissue 
Transplantation: Steering Medical Progress to Ethical Cures, 68 TEX. L. REV. 213, 
235 (1989). 	  
107 See Zion, supra note 103, at 1286. 
108 See id. 
109 See id. 
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As discussed in Part I.A., federal regulations already address 
concerns surrounding encouragement of abortions.  Women are 
specifically prohibited from having an abortion to donate to a 
cherished cause, or to choose that the tissue will be transplanted as 
“specified,” as stated in 42 U.S.C. §289g-2(b).110  Researchers are 
additionally prohibited from having any involvement when women 
could be encouraged to abort. Federal Regulations not only prohibit 
any inducements to end a pregnancy “monetary or otherwise,” but it 
restricts researchers from having any “part in any decisions as to the 
timing, method, or procedures used to terminate a pregnancy.”111  
 
Lastly, opponents of fetal tissue donation also argue that the 
practice is immoral.112  These opponents argue that because abortion, 
in their view, is “murder,” fetal tissue donation uses materials 
produced from murder, and is therefore unethical.113  This standpoint 
seems to be most popular in the arguments advanced in the political 
realm.  Former Speaker of the House of Representatives, John 
Boehner, has described fetal tissue donation as merely a “gruesome 
industry,” 114  and former presidential candidate Ben Carson has 
described it as “barbaric.”115 Senator Ted Cruz suggested constituents 
to watch the Center for Medical Progress videos and “[a]sk yourself,” 
he urged, “are these my values?”116 
 
Certainly the use of fetal tissue donated from induced abortions 
requires true moral considerations.  Although federal regulations 
prohibit the actions associated with undue influence or inducements of 
abortion, no federal statute or regulation can resolve humanity’s moral 
differences.  While individuals are entitled to differences in moral 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
110 42 U.S.C. § 289g-2(b) (2006). 
111 45 C.F.R. § 46.204(h)-(i) (2015). 
112 Zion, supra note 103, at 1287–88.	  
113 Id. 
114 Sarah Ferris, Republicans Double Down on Planned Parenthood Probe, THE 
HILL (Oct. 14, 2015), http://thehill.com/policy/healthcare/256840-republicans-
double-down-on-planned-parenthood-probe.  
115 Daniel Strauss, Carson Once Squeamish on Anti-Abortion Ad, POLITICO (July 28, 
2015), http://www.politico.com/story/2015/07/ben-carson-anti-abortion-ad-
commercial-squeamish-120720.  
116 Susan Berry, Ted Cruz Blasts GOP Leaders for Funding Planned Parenthood, 
BRIET BART (Sept. 28, 2015), http://www.breitbart.com/big-
government/2015/09/28/ted-cruz-blasts-gop-leaders-funding-planned-parenthood/.  
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opinion, such differences must not stand as a barrier to successful 
scientific and medical research that has saved the lives and improved 
the health of countless individuals.  
 
III. A PROPOSAL FOR CHANGE 
A. The Issue  
 
For fetal tissue donation to continue to be beneficial for society 
and useful for researchers, state statutes governing fetal tissue must be 
revised so that they are clear and easy to understand.  Specifically, 
such statutes must clarify to whom they apply, which actions are 
prohibited, and what the repercussions of violating the statute are.  
Such revisions will provide states the opportunity to successfully 
enforce safe and legal donations of fetal tissue. 
 
Despite the overwhelming importance of fetal tissue donation, 
interpreting state statutory language governing fetal tissue donation is 
challenging.  While fetal tissue donation is plainly allowed under the 
statutes of nine states, the status of fetal tissue donation in the 
remainder of states is less clear.117  Most states are simply silent or 
ambiguous on the topic of donation of fetal tissue from induced 
abortions.118  Although Planned Parenthood only donated fetal tissue 
in states that do not restrict donation, clinics facilitating fetal tissue 
donation commonly face restrictive or ambiguous state statutes. 
 
One explanation for the ambiguity involving fetal tissue 
donation throughout the United States could be the number of ethical 
challenges surrounding drafting fetal tissue donation legislation119; 
therefore, concerns that fetal tissue will be donated absent consent of 
the mother, or that unintentionally aborted live fetuses will be 
subjected to experimentation, must be considered.  While state 
legislators undoubtedly are tasked with the challenge of preventing use 
of fetal tissue without a woman’s consent, or protection of fetuses 
unintentionally aborted alive, statutory language drafted with clear and 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
117 See supra Section I.B. 
118 See supra Section I.B. 
119 See James E. Goddard, Comment, The NIH Revitalization Act of 1993 Washed 
Away Many Legal Problems with Fetal Tissue Transplantation Research but a Stain 
Still Remains, 49 SMU L. REV. 375, 385, 389 (1996) (discussing these concerns).   
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concise conditions will both satisfy opponents’ concerns and allow 
fetal tissue donation. 
 
B. The Remedy  
 
 This Section proposes a two-part revision for state legislation 
governing fetal tissue donation that state legislatures should implement 
in order to clearly enact fetal tissue donation legislation.  This proposal 
will adequately remedy opponents’ concerns, while also allowing the 
donation of fetal tissue.  Part I applies only to states which do not 
currently include fetuses from induced abortions in their state UAGA 
definitions of a decedent.  Part II applies to all states. 
 
1. Part I 
 
States that currently do not include fetal tissue in their 
definitions of decedent, or prohibit fetal tissue from induced abortions, 
should revise language to include fetal tissue from induced abortions. 
Since 1.2 million abortions occur each year, excluding aborted fetal 
tissue from tissue that can be donated results in an unnecessary waste 
of valuable fetal materials.120  Any concerns associated with donating 
fetal tissue from induced abortions will be remedied in Part 2.  An 
example of such a revision is as follows: ‘“Decedent” means a 
deceased individual and includes a stillborn infant or fetus.’”121  
 
Defining decedent broadly as proposed here would clarify 
ambiguity as to what sources of fetal tissue may be used for research.  
Limiting sources of fetal tissue to those other than abortions 
diminishes the vast majority of suitable tissue available for 
donation. 122   This definition will remedy the limitations that a 
restrictive definition imposes, as seen with many state UAGA’s, such 




2. Part II 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
120 See supra, Section 1.A. 
121 See DEL. CODE ANN. tit. 16, § 2710 (West 2016).   
122 See supra, Section 2.A(3)(b). 
123 See supra, Section 1.A; IOWA CODE ANN. § 142C.2 (2007). 
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Each state should adopt the following language from Rhode 
Island’s General Laws.124  This statute, entitled “Experimentation on 
human fetuses” would work in addition to the relevant state-enacted 
UAGA definition of decedent to allow donation of fetal tissue only 
within clearly specified restrictions.  
 
(a) No person shall use any live human fetus, whether 
before or after expulsion from its mother's womb, for 
scientific, laboratory research, or other kind of 
experimentation.  This section shall not prohibit 
procedures incident to the study of a human fetus while 
it is in its mother's womb, provided that in the best 
medical judgment of the physician, made at the time of 
the study, the procedures do not substantially 
jeopardize the life or health of the fetus, and provided 
the fetus is not the subject of a planned abortion.  In 
any criminal proceeding the fetus shall be conclusively 
presumed not to be the subject of a planned abortion if 
the mother signed a written statement at the time of the 
study that she was not planning an abortion. 
(b) This section shall not prohibit or regulate diagnostic 
or remedial procedures, the purpose of which is to 
determine or to preserve the life or health of the fetus 
involved or the mother involved. 
(c) A fetus is a live fetus for purposes of this section 
when, in the best medical judgment of a physician, it 
shows evidence of life as determined by the same 
medical standards as are used in determining evidence 
of life in a spontaneously aborted fetus at 
approximately the same stage of gestational 
development. 
(d) No experimentation may knowingly be performed 
upon a dead fetus unless the consent of its mother has 
first been obtained, provided, that such consent shall 
not be required in the case of a routine pathological 
study.  In any criminal proceeding, consent shall be 
conclusively presumed to have been granted for the 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
124 R.I. GEN. LAWS ANN. § 11-54-1 (2015).  
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purposes of this section by a written statement, signed 
by the mother, who is at least eighteen (18) years of 
age, to the effect that she consents to the use of her 
fetus for scientific, laboratory, research, or other kind 
of experimentation or study; that written consent shall 
constitute lawful authorization for the transfer of the 
dead fetus. 
(e) No person shall perform or offer to perform an 
abortion where part or all of the consideration for the 
performance is that the fetal remains may be used for 
experimentation or other kinds of research or study. 
(f) No person shall knowingly sell, transfer, distribute, 
or give away any fetus for a use which is in violation of 
the provisions of this section. For purposes of this 
section, the word “fetus” includes an embryo or 
neonate.125 
 
This “Experimentation on human fetuses” statute provides 
specific regulations to remedy concerns associated with fetal tissue 
donation. This statute first addresses concerns over protecting fetuses 
unintentionally aborted alive in sections (a) and (c).  By clearly 
defining when a fetus is alive in section (c), this language leaves a 
specific understanding of when donation of fetal tissue is prohibited.  
Specifically, if a fetus shows any “evidence of life” under medical 
standards, experimentation is strictly prohibited.  Section (a) further 
clarifies that under no circumstances should a live fetus, “before or 
after expulsion from its mother’s womb,” be used for experimentation.  
 
This statute also protects against opponents’ concerns 
involving consent of donated materials.  Section (d) provides that 
experimentation may be performed upon a dead fetus only with 
“consent of its mother has first been obtained.”  Violation of obtaining 
prior written approval from a consenting mother will result in criminal 
proceedings, as set out in section (d).  The language in section (d) not 
only protects donations only upon consent, but it also protects 
researchers from liability by specifically explaining under what 
conditions consent will “presumed” to have been given.  
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
125 Id.  
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Lastly, this statute prohibits inducements for abortion, and 
clarifies which circumstances the statute applies to.  Section (e) 
responds to concerns over women aborting to donate expressed in 
Section 2.B. above by restricting abortions procured wholly in or part 
as consideration for use of resulting fetal tissue in research.  Section 
(f) prohibits sale or any use of an aborted fetus that is in violation of 
the “Experimentation on human fetuses” section.  Lastly, section (b) 
leaves no room for ambiguity, by clarifying that restrictions imposed 
by the statute do not apply to diagnostic or remedial life-saving 
procedures for the mother or fetus.  By allowing fetal tissue donation 
under clear, comprehensive, and concise regulations and restrictions, 




 Contrary to the recent allegations by anti-abortion group 
Center for Medical Progress, Planned Parenthood’s actions are not in 
violation of either federal or state law.  The reasonable 
reimbursements Planned Parenthood formerly received were paid in 
accordance with federal law, and facilitation of fetal tissue donation in 
Oregon, Washington, and California is in accordance with state law.  
Since fetal tissue continues to be vital to scientific and medical 
research advances, donation of fetal tissue is imperative across the 
United States.  States that prohibit or ambiguously govern fetal tissue 
donation should revise statutory language in order to resolve 
ambiguity and remedy concerns expressed against fetal tissue research 
by opponents.  By adopting the language proposed above, states will 
adequately respond to arguments advanced against fetal tissue 
donation, while facilitating potentially ground-breaking research.  
 
